...
首页> 外文期刊>Advances in Experimental Medicine and Biology >miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease
【24h】

miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease

机译:与糖尿病和非酒精脂肪肝病相关的葡萄糖和脂质代谢的miRNA调节

获取原文
获取原文并翻译 | 示例
           

摘要

Glucose and lipids are important nutrients because they provide most of the energy for the cells. A pre-translational regulation by microRNAs (miRNAs) plays a pivotal role in cellular metabolism by targeting the key rate-limiting enzymes of relevant pathways to fine-tune control of metabolic homeostasis. Aberrant expression of these miRNAs can result in an over or under expression of those key enzymes, contributing to the etiology of diabetes and non-alcoholic fatty liver disease (NAFLD). Here we discuss recent studies of various miRNAs that control insulin sensitivity, hepatic glucose production and de novo lipogenesis and how aberrant expression of these miRNAs contributes to the pathophysiology of diabetes and NAFLD in animal models. We also review the current application of circulating miRNAs as biomarkers for diagnosis or disease monitoring in diabetes and NAFLD.
机译:葡萄糖和脂质是重要的营养素,因为它们为细胞提供了大部分能量。 通过靶向相关途径的关键率限制酶对代谢性稳态的微调控制来说,MicroRNAS(miRNA)的预翻译作用在细胞代谢中起着枢轴作用。 这些miRNA的异常表达可以导致这些关键酶的表达,导致糖尿病和非酒精性脂肪肝病(NAFLD)的病因。 在这里,我们讨论最近对各种MiRNA的研究,可控制胰岛素敏感性,肝葡萄糖生产和DE Novo脂肪生成以及这些miRNA的异常表达如何导致动物模型中糖尿病和NAFLD的病理生理学。 我们还审查了当前循环miRNA作为生物标志物进行糖尿病和NAFLD诊断或疾病监测的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号